Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Purchases 15,363 Shares

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 15,363 shares of the company’s stock in a transaction dated Wednesday, April 17th. The shares were purchased at an average cost of $1.03 per share, with a total value of $15,823.89. Following the acquisition, the chief executive officer now owns 14,352,831 shares of the company’s stock, valued at approximately $14,783,415.93. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.

Retractable Technologies Price Performance

Shares of RVP traded down $0.02 during mid-day trading on Thursday, hitting $1.02. 76,907 shares of the company traded hands, compared to its average volume of 78,911. Retractable Technologies, Inc. has a one year low of $0.95 and a one year high of $1.88. The company has a current ratio of 8.28, a quick ratio of 6.41 and a debt-to-equity ratio of 0.01. The business has a 50-day moving average of $1.21 and a 200 day moving average of $1.16. The stock has a market capitalization of $30.54 million, a price-to-earnings ratio of -4.29 and a beta of 2.11.

Institutional Trading of Retractable Technologies

Several hedge funds have recently modified their holdings of RVP. Jane Street Group LLC bought a new stake in shares of Retractable Technologies during the fourth quarter valued at approximately $27,000. Cubist Systematic Strategies LLC bought a new position in Retractable Technologies in the second quarter valued at approximately $40,000. Dimensional Fund Advisors LP bought a new position in Retractable Technologies in the third quarter valued at approximately $52,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new position in Retractable Technologies in the second quarter valued at approximately $54,000. Finally, Virtu Financial LLC bought a new position in Retractable Technologies in the second quarter valued at approximately $57,000. 7.58% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of Retractable Technologies in a research note on Wednesday. They set a “hold” rating on the stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.